Cambridge Enterprise has unveiled a new strategic program, Leaps, designed to propel local companies onto the global stage by embedding them in key innovation ecosystems. This initiative will provide selected founders with vital access to new markets, talent, and investment opportunities. The inaugural phase, the London Leap, is launched in collaboration with partners Phoenix Court, Balderton Capital, and the BioInnovation Institute Foundation to foster growth and success.
Bridging Two Innovation Powerhouses
The initiative strategically connects two of the UK's most powerful and complementary innovation hubs, aiming to amplify their collective strengths. Cambridge is globally recognized for its innovation output per capita, ranking just behind the Bay Area and Boston, and is a hotbed for world-renowned university research. This program seeks to translate that academic excellence into commercial success by leveraging London's dynamic ecosystem for scaling businesses.
A Collaborative Launch with Industry Leaders
The London Leap is supported by a consortium of influential global partners, including venture capital firms Phoenix Court and Balderton Capital, alongside the BioInnovation Institute Foundation. This collaboration will initially provide space for three Cambridge startups to integrate into London's thriving tech scene. The city is recognized as Europe's leading tech ecosystem, attracting significant international capital and boasting a strong track record of creating unicorn companies.
Expert Guidance and Competitive Selection
Startups will be invited to apply for the program and will be selected through a competitive process overseen by the partners and a distinguished advisory board. This board comprises seasoned investors and serial entrepreneurs, ensuring that the chosen companies receive top-tier guidance. Members include Susan Hill, CEO of Mestag Therapeutics, and Dr Bobby Yerramilli-Rao, Chief Strategy Officer at Microsoft, among other industry leaders.
A Vision for Global Expansion
According to Jim Glasheen, CEO of Cambridge Enterprise, companies cannot effectively scale in isolation, highlighting the importance of creating meaningful connections in globally connected hubs. He emphasized that London is merely the first step in a much broader, global proposition for the Leaps initiative. The long-term vision is to identify and establish similar landing spots in other key international ecosystems to support Cambridge-born companies worldwide.
Partners have voiced strong support for the program's ambition, with Suranga Chandratillake of Balderton noting Cambridge's history of producing exciting deep tech companies. Julia Hawkins of Phoenix Court highlighted the opportunity to connect these businesses with global markets and talent earlier. Jen Nielsen of the BioInnovation Institute also expressed enthusiasm for strengthening the bridge between innovation hubs and commercializing outstanding scientific research.
The launch of the Leaps initiative marks a significant development in the UK's technology and life sciences sectors, fostering greater synergy between Cambridge's research prowess and London's commercial might. By providing a structured pathway to global markets, the program is poised to accelerate the growth of the next generation of innovators. This strategic collaboration ultimately aims to solidify the UK's position as a global leader in science-based commercial innovation.